• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Bosch Ventures: Investment Portfolio & Startup News

Bosch Ventures

To add a bio or update investment portfolio click update information.

Investment Portfolio

    Humanoid unlocks £114m Series A led by Prime Movers Lab to deploy humanoid robots across industrial manufacturing and logisticsHumanoid unlocks £114m Series A led by Prime Movers Lab to deploy humanoid robots across industrial manufacturing and logistics
    Humanoid
    21 Jul 2026

    Humanoid unlocks £114m Series A led by Prime Movers Lab to deploy humanoid robots across industrial manufacturing and logistics

    Humanoid is a UK-based AI and robotics company building humanoid robots for industrial use. Its vertically integrated robots combine proprietary hardware with an in-house AI brain, KinetIQ, enabling them to understand, reason and execute physical tasks across manufacturing, logistics, retail and other industrial environments.

    CamGraPhIC raises £20m Series A led by CDP Venture Capital to develop graphene-based optical transceiversCamGraPhIC raises £20m Series A led by CDP Venture Capital to develop graphene-based optical transceivers
    CamGraPhIC
    24 Mar 2025

    CamGraPhIC raises £20m Series A led by CDP Venture Capital to develop graphene-based optical transceivers

    CamGraPhIC develops graphene-based optical transceivers that move large volumes of data between chips with far lower energy use, supporting applications such as AI computing, advanced data centres and high performance systems.

Bosch Ventures
    • Industrial
    • Deep Tech
  • 1(12 months)
  • bosch.ventures

More venture news

  • Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre
    Zya
    16 Nov 2026

    Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre

    Series AHealth
  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences
  • UFORCE secures a £530m Series A round led by Valor Equity Partners and UK National Wealth Fund to build uncrewed defence platforms
    UFORCE
    12 Nov 2026

    UFORCE secures a £530m Series A round led by Valor Equity Partners and UK National Wealth Fund to build uncrewed defence platforms

    Series ADefence

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn